The Tasso+ device is a state-of-the-art, virtually painless blood collection system designed to streamline sampling while maximizing patient comfort. Applied to the upper arm, Tasso+ uses gentle vacuum technology to draw high-quality capillary blood—eliminating the need for needles and reducing patient anxiety.

Its compact, single-use format makes it ideal for decentralized clinical trials, remote testing, and other settings where convenience and sample integrity are paramount. With minimal training required, Tasso+ enables consistent collection volumes, high patient compliance, and reliable results, all in a safe, user-friendly package.

The Tasso+ device offers a painless, needle-free solution for blood collection, enhancing patient comfort and compliance. Its compact, single-use design ensures hygienic, reliable sampling with consistent volumes of 300–600 µL. Ideal for decentralized trials, home testing, and clinical settings, the Tasso+ simplifies workflows, reduces anxiety, and delivers high-quality samples compatible with a broad range of assays.

Sample Type: Liquid capillary blood.

Collection Volume: 300–600 µL per draw.

Design: Single-use, compact, lightweight.

Technology: Vacuum-assisted collection for reliable, high-quality samples.

Application Site: Upper arm.

Collection Time: ~5–10 minutes.

Patient Experience: Virtually painless and needle-free.

Compatibility: Supports a range of laboratory tubes (e.g., EDTA, SST).

Safety: Hygienic design prevents cross-contamination.

Use Cases: Ideal for decentralized trials, home testing, and clinical settings.

The Tasso+ device supports a wide range of assays, including:

– Clinical Chemistry: Glucose, cholesterol, creatinine.

– Hematology: Complete Blood Count (CBC).

– Serology: Antibody detection, including SARS-CoV-2 IgG.

– Endocrinology: Cortisol, thyroid hormones, estradiol, TSH.

– Cardiology: Lipid panels and hsCRP.

– Diabetes: HbA1c.

– Liver Function: ALT, AST, bilirubin, albumin.

– Kidney Function: Cystatin C, BUN, creatinine.

The Tasso+ device supports a wide range of assays that utilize liquid capillary blood, making it suitable for various clinical and diagnostic applications. Compatible assays include:

Chemistry Panels: Basic and comprehensive metabolic panels.

Hematology: Complete blood counts (CBC) and differential analyses.

Serology: Antibody detection, including SARS-CoV-2 IgG assays.

Endocrinology: Hormone levels (e.g., cortisol, thyroid hormones, estradiol).

Cardiology: Lipid profiles (cholesterol, HDL, LDL, triglycerides) and cardiac biomarkers (e.g., hsCRP).

Diabetes Monitoring: HbA1c and glucose tests.

Liver Function Tests: ALT, AST, total bilirubin, and albumin levels.

Kidney Function: Creatinine, cystatin C, and BUN tests.

The quality of blood drawn using the Tasso+ device can be determined through several key assessments:

Visual Inspection: Examine the sample for signs of hemolysis (pink or red discoloration), clots, or contamination. A clear, uniformly colored sample indicates good quality.

Sample Volume: Confirm the collected volume (300–600 µL) meets the requirements for the intended assays.

Tube Handling: Ensure proper mixing of blood in tubes containing anticoagulants or additives (e.g., EDTA, SST) by following recommended procedures, such as gentle inversion.

Laboratory Testing: Perform quality control checks during laboratory analysis to assess sample integrity, including hemolysis, hematocrit levels, and analyte stability.

Consistency with Reference Values: Compare test results from Tasso+ samples with venous blood draws to verify reliability and accuracy. Studies have shown Tasso+ samples provide results comparable to venous draws for most analytes.

Adherence to Protocols: Follow the device’s instructions for use to ensure optimal performance and minimize potential errors during collection.